



To the Editor: A tsunami devastat-
ed coastal areas of the Indian Ocean
rim in December 2004. Of the affected
countries, more than half of the
≈300,000 deaths occurred in the Aceh
Province of Indonesia, close to the epi-
center of the earthquake near northern
Sumatra. Infrastructure, including
medical and laboratory facilities, in
this region was severely damaged. Of
>1,000,000 survivors, >500,000 likely
were injured. Most injuries were from
trauma, but a substantial number were
caused by aspiration of, or immersion
in, saltwater that may have been con-
taminated by soil, sewage, or other
environmental sources.
Melioidosis, caused by the sapro-
phytic gram-negative bacillus Burk-
holderia pseudomallei, is endemic in
Southeast Asia and northern Australia.
Most cases have been found in north-
eastern Thailand, Singapore, and
northern Australia. Melioidosis has
been reported only sporadically from
Indonesia and mainly in returning
travelers (1–3). 
In the context of acute medical
relief efforts to the town of Banda
Aceh, we report on 10 patients with
pneumonia, including 4 patients with
culture-confirmed melioidosis, after
their immersion in contaminated salt-
water during the tsunami. Clinical and
laboratory services were reestablished
on January 3, 2005, at Fakinah
Hospital and on January 13, 2005, at
Zainoel Abidin Hospital by the relief
teams. Patients were identified oppor-
tunistically; details of treatment and
outcome were reviewed retrospective-
ly. Cultures were taken when clinical-
ly indicated and when specimens
were available. Sputum cultures were
plated onto horse blood agar, cystine
lactose electrolyte-deficient agar,
Haemophilus agar, and colistin/
nalidixic acid blood agar incubated in
a candle jar at 35°C for <3 days.
Colonies suspicious for B. pseudoma-
llei were subcultured to B. cepacia–
selective media (Oxoid, Adelaide,
South Australia, Australia). Blood
cultures and screening cultures of
throat and rectum specimens were not
performed routinely. Isolates of B.
pseudomallei and characteristic
antimicrobial drug susceptibilities
were confirmed with API20NE
(bioMérieux, Marcy l’Etoile, France). 
From January 3 to January 28,
2005, a total of 10 cases of postim-
mersion pneumonia were identified.
All patients were <18 years of age and
previously well; 6 were male. No
cases were epidemiologically linked
to others. The patients were treated
10–35 days after the tsunami. Eight
had bilateral alveolar opacities on
chest radiograph; 3 also had empye-
ma. Clinical, radiologic, and microbi-
ologic details are summarized in the
online Table (Available from
http://www.cdc.gov/ncidod/EID/vol
11no10/05-0740.htm#table).
The sputum cultures of 4 patients
were positive for B. pseudomallei.
Except posttsunami exposure, none
had risk factors for melioidosis,
including diabetes, renal failure, or
thalassemia. Other co-isolated organ-
isms included Pseudomonas aerugi-
nosa and Klebsiella sp.; 2 patients
who did not have cultures taken had
cavitatory lung disease. All patients
with melioidosis were treated with
meropenem, and all but 1 clinically
improved in the hospital.
This is the second report of melioi-
dosis from within Indonesia (1) and
the second published report of melioi-
dosis after the tsunami disaster (4).
Cases from this event were included
in a preliminary communication (5).
However, exported cases of melioido-
sis from Indonesia, as well as the
neighboring countries of Singapore
and Malaysia, have been reported pre-
viously (2,3), a likely indication that
this infection is underrecognized in
Indonesia. Melioidosis has also been
reported in tsunami survivors from Sri
Lanka (4) and Thailand.
A striking feature of this event is
the lack of predisposing factors and
the young age of the patients. This
feature likely represents the unique
mode of acquisition and magnitude of
the infecting inoculum, as well as the
vulnerability of children to near
drowning after flooding. One third of
the patients had empyema, which
reflects both the severity of pul-
monary disease and delay in receiving
medical care. Undoubtedly, a substan-
tial selection bias occurred by includ-
ing only patients who sought hospital
treatment, and this is suggested by the
low death rate. Melioidosis, acquired
after near drowning, has been associ-
ated with a short incubation period
and severe disease. However, patients
who had melioidosis before medical
aid arrived in the region would likely
have died. Patients with longer incu-
bation periods also may have acquired
melioidosis through contaminated
wounds with subsequent hematoge-
nous dissemination.
Medical services to the region
were by no means comprehensive
during this time. Many other patients
with postimmersion pneumonia and
melioidosis may have been over-
looked, both during the study (for per-
sons who were not treated or if cul-
tures were not taken) and afterwards;
the incubation period of melioidosis
may be <62 years. A further limitation
is the lack of denominator data
because no reliable records were kept
on hospital admissions, and the exact
number of survivors is not yet known.
Conflicting data are found on the
accuracy of the API20NE test kit used
to identify bacteria in this study (6–9),
but we believe that the clinical fea-
tures and microbiologic findings sug-
gest melioidosis.
This report confirms that B.
pseudomallei exists in the Aceh
Province of Indonesia and that melioi-
dosis and gram-negative pneumonia
may complicate saltwater immersion
in this region. After near drowning
incidents, melioidosis is characterized
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by severe pulmonary disease, includ-
ing pleural effusions. Clinicians
worldwide should be mindful that
melioidosis in tsunami survivors may
appear many years after exposure.
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Chytrid Fungus in
Europe 
To the Editor: Amphibian species
are declining at an alarming rate on a
global scale (1). One of the major rea-
sons for these declines is chytrid-
iomycosis, caused by the chytrid-
iomycete fungus, Batrachochytrium
dendrobatidis (1,2). This pathogen of
amphibians has recently emerged
globally (2,3) and has caused mass
die-offs and extensive species
declines on 4 continents (1,3); knowl-
edge of its distribution and effects on
amphibian populations remains poor.
In Europe, little is known about B.
dendrobatidis distribution, which is
disturbing when one considers that at
least 3 European amphibian species
are undergoing chytrid-associated
die-offs that will likely lead to local
extinction (4,5) (J. Bosch et al.,
unpub. data).
We screened 1,664 current and
archived samples of wild amphibians
collected in Europe from 1994 to
2004 by researchers using amphibians
as study organisms. B. dendrobatidis
infects the skin of adult amphibians
and the mouthparts of anuran larvae;
samples included toe clippings and
skin samples from adults and mouth-
parts of tadpoles. Our sampling was
opportunistic, including both caudates
and anurans. We screened all samples
for chytrid fungus with quantitative
real-time polymerase chain reaction
(PCR) of the ITS-1/5.8S ribosomal
DNA region of B. dendrobatidis (6),
including appropriate positive and
negative controls. We confirmed real-
time PCR positives by amplifying a
subset of these positives with a sec-
ond B. dendrobatidis–specific PCR
with a nested reaction developed from
the ctsyn1 locus (3). To confirm that
detection with real-time PCR indicat-
ed a viable chytrid infection, when
actual tissue samples were available,
we examined a generous subset using
histologic features for typical signals
of pathogenic B. dendrobatidis infec-
tion. Specifically, we found intracel-
lular zoospore-carrying sporangia
within the stratum corneum and stra-
tum granulosum of toe and skin sam-
ples. We also compared real-time
PCR amplification profiles of sus-
pected positives to those generated
from samples from animals involved
in chytrid-driven die-offs and found
these results to be comparable.
Furthermore, attempts to isolate the
fungus from dead animals were suc-
cessful when animals were obtained
in a suitable condition for this purpose
(see below).
Our survey found B. dendrobatidis
in amphibians in 5 European coun-
tries, Spain, Portugal, Italy,
Switzerland, and Great Britain.
Previously, chytrid infection has been
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